ConductScience.org, home

Paper8920173

Thrombolytic therapy in the elderly. Pharmacoeconomic considerations.

Ramanathan K and 2 others. Drugs Aging, 1996. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Thrombolytic therapy in the elderly. Pharmacoeconomic considerations. Papers, record 8920173. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8920173

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Thrombolytic therapy in the elderly. Pharmacoeconomic considerations.
PubMed
Journal
Drugs Aging
PubMed
Year
1996
PubMed
Publication types
Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.31
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ramanathan KK
2Ellis CJC J
3White HDH D

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Myocardial InfarctionMajor topic
Plasminogen ActivatorsMajor topic
Thrombolytic TherapyMajor topic
Tissue Plasminogen ActivatorMajor topic
Aged
Cost-Benefit Analysis
Humans

Source PubMed

Download CSV of topics

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12373810Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators.J Am Coll Cardiol1990https://conductscience.org/library/papers/2373810PubMed
27666904Is the use of t-PA as compared with streptokinase cost effective?N Engl J Med1995https://conductscience.org/library/papers/7666904PubMed
37585772Selecting a thrombolytic agent.Cardiol Clin1995https://conductscience.org/library/papers/7585772PubMed
48232430The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.N Engl J Med1993https://conductscience.org/library/papers/8232430PubMed
51975321
GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
Lancet1990https://conductscience.org/library/papers/1975321PubMed
67723799Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.N Engl J Med1995https://conductscience.org/library/papers/7723799PubMed
77666905Is the use of t-PA as compared with streptokinase cost effective?N Engl J Med1995https://conductscience.org/library/papers/7666905PubMed
83598017Cardiovascular care of the elderly: economic considerations.J Am Coll Cardiol1987https://conductscience.org/library/papers/3598017PubMed
92894490Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group.Lancet1988https://conductscience.org/library/papers/2894490PubMed
102871492A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.N Engl J Med1986https://conductscience.org/library/papers/2871492PubMed
118475884Thrombolytic therapy for acute myocardial infarction in a 110-year-old man.Am J Cardiol1993https://conductscience.org/library/papers/8475884PubMed
121975322
In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.
Lancet1990https://conductscience.org/library/papers/1975322PubMed
131452917Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials.J Am Coll Cardiol1992https://conductscience.org/library/papers/1452917PubMed
143132962
Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands.
Br Heart J1988https://conductscience.org/library/papers/3132962PubMed
152900919Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).Lancet1988https://conductscience.org/library/papers/2900919PubMed
164178977A new coronary prognostic index.Lancet1969https://conductscience.org/library/papers/4178977PubMed
172868337Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).Lancet1986https://conductscience.org/library/papers/2868337PubMed
182002574Coronary thrombolysis for the elderly?JAMA1991https://conductscience.org/library/papers/2002574PubMed
191869726Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group.J Am Coll Cardiol1991https://conductscience.org/library/papers/1869726PubMed
208070474Eligibility for reperfusion therapy and outcome in elderly patients with acute myocardial infarction.Eur Heart J1994https://conductscience.org/library/papers/8070474PubMed

See all 46 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
11558833Management of acute ischaemic stroke in the elderly: tolerability of thrombolytics.Drugs2001https://conductscience.org/library/papers/11558833PubMed
10408741Thrombolysis versus primary angioplasty in older patients with acute myocardial infarction.Drugs Aging1999https://conductscience.org/library/papers/10408741PubMed
9883399Utilisation of thrombolytic therapy in older patients with myocardial infarction.Drugs Aging1998https://conductscience.org/library/papers/9883399PubMed
9812927Age related outcome in acute myocardial infarction. Elderly people benefit from thrombolysis and should be included in trials.BMJ1998https://conductscience.org/library/papers/9812927PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8920173

GET https://conductscience.org/api/papers/v1/8920173/references?page=2